$11.4 Billion is the total value of ArrowMark Colorado Holdings LLC's 343 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| YSACW | Exit | YELLOWSTONE ACQUISITION CO*w exp 10/21/202 | $0 | – | -74,300 | -100.0% | 0.00% | – |
| LBTYA | Exit | LIBERTY GLOBAL PLC | $0 | – | -20,000 | -100.0% | -0.00% | – |
| INFO | Exit | IHS MARKIT LTD | $0 | – | -6,739 | -100.0% | -0.01% | – |
| FMACU | Exit | FIRSTMARK HORIZON ACQUISITIOunit 99/99/9999 | $0 | – | -89,149 | -100.0% | -0.01% | – |
| FMAC | Exit | FIRSTMARK HORIZON ACQUISITIO | $0 | – | -100,921 | -100.0% | -0.01% | – |
| YSAC | Exit | YELLOWSTONE ACQUISITION CO | $0 | – | -130,400 | -100.0% | -0.01% | – |
| LYV | Exit | LIVE NATION ENTERTAINMENT IN | $0 | – | -25,000 | -100.0% | -0.02% | – |
| Exit | GINKGO BIOWORKS HOLDINGS INC | $0 | – | -6,779 | -100.0% | -0.05% | – | |
| DNAY | Exit | CODEX DNA INC | $0 | – | -563,294 | -100.0% | -0.05% | – |
| Exit | ADAGIO THERAPEUTICS INC | $0 | – | -1,024,510 | -100.0% | -0.05% | – | |
| GHM | Exit | GRAHAM CORP | $0 | – | -518,755 | -100.0% | -0.05% | – |
| Exit | RYAN SPECIALTY GROUP HLDGS Icl a | $0 | – | -174,498 | -100.0% | -0.06% | – | |
| APO | Exit | APOLLO GLOBAL MGMT INC | $0 | – | -113,269 | -100.0% | -0.07% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -156,924 | -100.0% | -0.08% | – |
| Exit | WEAVE COMMUNICATIONS INC | $0 | – | -743,849 | -100.0% | -0.09% | – | |
| MNRO | Exit | MONRO INC | $0 | – | -224,000 | -100.0% | -0.10% | – |
| FHN | Exit | FIRST HORIZON CORPORATION | $0 | – | -1,126,000 | -100.0% | -0.15% | – |
| XMTR | Exit | XOMETRY INC | $0 | – | -472,902 | -100.0% | -0.19% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -2,716,826 | -100.0% | -0.56% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -909,722 | -100.0% | -0.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COOPER COS INC | 42 | Q3 2023 | 1.7% |
| SPDR GOLD TRUST | 42 | Q3 2023 | 6.4% |
| CITIGROUP INC | 42 | Q3 2023 | 10.1% |
| CHENIERE ENERGY INC | 42 | Q3 2023 | 3.0% |
| JPMORGAN CHASE & CO | 42 | Q3 2023 | 5.7% |
| EOG RES INC | 42 | Q3 2023 | 1.8% |
| MICROSOFT CORP | 42 | Q3 2023 | 0.7% |
| APPLE INC | 42 | Q3 2023 | 1.0% |
| WEYERHAEUSER CO MTN BE | 42 | Q3 2023 | 1.5% |
| WALKER & DUNLOP INC | 42 | Q3 2023 | 0.7% |
View ArrowMark Colorado Holdings LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| C4 Therapeutics, Inc. | June 12, 2023 | 1,493,450 | 3.0% |
| Frontdoor, Inc. | May 10, 2023 | 3,463,478 | 4.2% |
| CHANNELADVISOR CORPSold out | February 15, 2023 | 0 | 0.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 15, 2023 | 3,560,848 | 3.0% |
| HUDSON TECHNOLOGIES INC /NY | February 15, 2023 | 2,091,927 | 4.6% |
| KnowBe4, Inc.Sold out | February 15, 2023 | 0 | 0.0% |
| MERIT MEDICAL SYSTEMS INC | February 15, 2023 | 2,517,226 | 4.4% |
| NexImmune, Inc. | February 15, 2023 | 10,924 | 0.0% |
| SKECHERS USA INC | February 15, 2023 | 4,332,217 | 3.2% |
| Talis Biomedical Corp | February 15, 2023 | 1,159,016 | 4.3% |
View ArrowMark Colorado Holdings LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ArrowMark Colorado Holdings LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.